Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases

Nanomedicine: Nanotechnology, Biology and Medicine - Tập 49 - Trang 102655 - 2023
Thomas Démoulins1,2,3,4,5, Kai Schulze6, Thomas Ebensen6, Navapon Techakriengkrai4,5, Teerawut Nedumpun4,5, Pavlos C. Englezou1,3, Markus Gerber1,3, Ruslan Hlushchuk7, Darien Toledo8, Valentin Djonov7, Stephan von Gunten8, Kenneth C. McCullough1,3, Matthias Liniger1,3, Carlos A. Guzmán6, Sanipa Suradhat4,5, Nicolas Ruggli1,3
1Institute of Virology and Immunology IVI, Bern & Mittelhäusern, Switzerland
2Institute of Veterinary Bacteriology, University of Bern, Bern, Switzerland
3Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland
4Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand
5Center of Excellence in Emerging Infectious Diseases in Animals, Chulalongkorn University (CU-EIDAs), Bangkok, Thailand
6Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
7Institute of Anatomy, University of Bern, Bern, Switzerland
8Institute of Pharmacology, University of Bern, Bern, Switzerland

Tài liệu tham khảo

Bloom, 2021, Self-amplifying RNA vaccines for infectious diseases, Gene Ther, 28, 117, 10.1038/s41434-020-00204-y

Ljungberg, 2015, Self-replicating alphavirus RNA vaccines, Expert Rev Vaccines, 14, 177, 10.1586/14760584.2015.965690

Tratschin, 2008

Vogel, 2018, Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses, Mol Ther, 26, 446, 10.1016/j.ymthe.2017.11.017

Blakney, 2021, An update on self-amplifying mRNA vaccine development, Vaccines (Basel), 9

Johansson, 2012, Intradermal electroporation of naked replicon RNA elicits strong immune responses, PLoS One, 7, 10.1371/journal.pone.0029732

Beissert, 2020, A trans-amplifying RNA vaccine strategy for induction of potent protective immunity, Mol Ther, 28, 119, 10.1016/j.ymthe.2019.09.009

de Alwis, 2021, A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice, Mol Ther, 29, 1970, 10.1016/j.ymthe.2021.04.001

Démoulins, 2020, Self-amplifying pestivirus replicon RNA encoding influenza virus nucleoprotein and hemagglutinin promote humoral and cellular immune responses in pigs, Front Immunol, 11

Ricklin, 2017, Virus replicon particle vaccines expressing nucleoprotein of influenza a virus mediate enhanced inflammatory responses in pigs, Sci Rep, 7, 16379, 10.1038/s41598-017-16419-w

Démoulins, 2017, Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure, J Control Release, 266, 256, 10.1016/j.jconrel.2017.09.018

Démoulins, 2017, Self-replicating RNA vaccine delivery to dendritic cells, Methods Mol Biol, 1499, 37, 10.1007/978-1-4939-6481-9_3

Démoulins, 2016, Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines, Nanomedicine, 12, 711, 10.1016/j.nano.2015.11.001

Englezou, 2018, Self-amplifying replicon RNA delivery to dendritic cells by cationic lipids, Mol Ther Nucleic Acids, 12, 118, 10.1016/j.omtn.2018.04.019

McCullough, 2014, Self-replicating replicon-RNA delivery to dendritic cells by chitosan-nanoparticles for translation in vitro and in vivo, Mol Ther Nucleic Acids, 3, 10.1038/mtna.2014.24

Kofler, 2004, Mimicking live flavivirus immunization with a noninfectious RNA vaccine, Proc Natl Acad Sci U S A, 101, 1951, 10.1073/pnas.0307145101

Piggott, 2009, Electroporation of RNA stimulates immunity to an encoded reporter gene in mice, Mol Med Rep, 2, 753

Rayner, 2002, Alphavirus vectors and vaccination, Rev Med Virol, 12, 279, 10.1002/rmv.360

Nathues, 2018, Modelling the economic efficiency of using different strategies to control porcine reproductive & respiratory syndrome at herd level, Prev Vet Med, 152, 89, 10.1016/j.prevetmed.2018.02.005

Zhao, 2021, Advanced research in porcine reproductive and respiratory syndrome virus co-infection with other pathogens in swine, Front Vet Sci, 8, 10.3389/fvets.2021.699561

Kasza, 1972, Establishment, viral susceptibility and biological characteristics of a swine kidney cell line SK-6, Res Vet Sci, 13, 46, 10.1016/S0034-5288(18)34087-6

Ebensen, 2011, Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant, Vaccine, 29, 5210, 10.1016/j.vaccine.2011.05.026

Mittal, 2015, Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination, J Control Release, 206, 140, 10.1016/j.jconrel.2015.03.017

Mittal, 2015, Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation, Nanomedicine, 11, 147, 10.1016/j.nano.2014.08.009

Suter, 2011, Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-alpha/beta and carry foreign genes, Vaccine, 29, 1491, 10.1016/j.vaccine.2010.12.026

Ruggli, 1996, Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA, J Virol, 70, 3478, 10.1128/jvi.70.6.3478-3487.1996

Wongyanin, 2012, Role of porcine reproductive and respiratory syndrome virus nucleocapsid protein in induction of interleukin-10 and regulatory T-lymphocytes (Treg), J Gen Virol, 93, 1236, 10.1099/vir.0.040287-0

Greiser-Wilke, 1990, Identification of conserved epitopes on a hog cholera virus protein, Arch Virol, 111, 213, 10.1007/BF01311055

Peters, 1986, Preliminary serological characterization of bovine viral diarrhoea virus strains using monoclonal antibodies, Vet Microbiol, 12, 195, 10.1016/0378-1135(86)90048-9

Liniger, 2012, Chicken cells sense influenza a virus infection through MDA5 and CARDIF signaling involving LGP2, J Virol, 86, 705, 10.1128/JVI.00742-11

Sharma, 2012, Synthetic virus-like particles target dendritic cell lipid rafts for rapid endocytosis primarily but not exclusively by macropinocytosis, PLoS One, 7, 10.1371/journal.pone.0043248

Frey, 2006, Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application, Vet Res, 37, 655, 10.1051/vetres:2006028

Akita, 2015, Molecular tuning of a vitamin E-scaffold pH-sensitive and reductive cleavable lipid-like material for accelerated in vivo hepatic siRNA delivery, ACS Biomater Sci Eng, 1, 834, 10.1021/acsbiomaterials.5b00203

Bauhofer, 2007, Classical swine fever virus npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation, J Virol, 81, 3087, 10.1128/JVI.02032-06

Ebensen, 2017, Mucosal administration of cycle-di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in mice, Front Immunol, 8, 1223, 10.3389/fimmu.2017.01223

Liu, 2016, Porcine reproductive and respiratory syndrome virus nucleocapsid protein interacts with Nsp9 and cellular DHX9 to regulate viral RNA synthesis, J Virol, 90, 5384, 10.1128/JVI.03216-15

Akita, 2013, A neutral envelope-type nanoparticle containing pH-responsive and SS-cleavable lipid-like material as a carrier for plasmid DNA, Adv Healthc Mater, 2, 1120, 10.1002/adhm.201200431

Akita, 2015, A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma, J Control Release, 200, 97, 10.1016/j.jconrel.2014.12.029

Shirane, 2018, Development of an alcohol dilution-lyophilization method for preparing lipid nanoparticles containing encapsulated siRNA, Biol Pharm Bull, 41, 1291, 10.1248/bpb.b18-00208

Togashi, 2018, A hepatic pDNA delivery system based on an intracellular environment sensitive vitamin E-scaffold lipid-like material with the aid of an anti-inflammatory drug, J Control Release, 279, 262, 10.1016/j.jconrel.2018.04.022

Ukawa, 2014, Neutralized nanoparticle composed of SS-cleavable and pH-activated lipid-like material as a long-lasting and liver-specific gene delivery system, Adv Healthc Mater, 3, 1222, 10.1002/adhm.201300629

Tanaka, 2021, Improvement of mRNA delivery efficiency to a T cell line by modulating PEG-lipid content and phospholipid components of lipid nanoparticles, Pharmaceutics, 13, 10.3390/pharmaceutics13122097

Madhun, 2011, Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice, Vaccine, 29, 4973, 10.1016/j.vaccine.2011.04.094

Pedersen, 2011, Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP, PLoS One, 6, 10.1371/journal.pone.0026973

Vashist, 2018, Influenza-activated ILC1s contribute to antiviral immunity partially influenced by differential GITR expression, Front Immunol, 9, 505, 10.3389/fimmu.2018.00505

Charerntantanakul, 2012, Porcine reproductive and respiratory syndrome virus vaccines: immunogenicity, efficacy and safety aspects, World J Virol, 1, 23, 10.5501/wjv.v1.i1.23

LeRoith, 2011, A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with mycoplasma hyopneumoniae, Vet Immunol Immunopathol, 140, 312, 10.1016/j.vetimm.2010.12.011

Suradhat, 2016, Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses, Vaccine, 34, 609, 10.1016/j.vaccine.2015.12.043

Sirisereewan, 2017, Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infection, Vet Immunol Immunopathol, 183, 7, 10.1016/j.vetimm.2016.11.002

Suradhat, 2015, A novel DNA vaccine for reduction of PRRSV-induced negative immunomodulatory effects: a proof of concept, Vaccine, 33, 3997, 10.1016/j.vaccine.2015.06.020

Thông tin
Thông tin xuất bản

Nanomedicine: Nanotechnology, Biology and Medicine

Tập 49

102655

Thông tin tác giả